Form 8-K - Current report:
SEC Accession No. 0001104659-22-058792
Filing Date
2022-05-11
Accepted
2022-05-11 16:11:41
Documents
16
Period of Report
2022-05-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2215190d1_8k.htm   iXBRL 8-K 31554
2 EXHIBIT 99.1 tm2215190d1_ex99-1.htm EX-99.1 68671
7 GRAPHIC tm2215190d1_ex99-1img01.jpg GRAPHIC 4200
8 GRAPHIC tm2215190d1_ex99-1img02.jpg GRAPHIC 3436
  Complete submission text file 0001104659-22-058792.txt   341110

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cycc-20220511.xsd EX-101.SCH 3271
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cycc-20220511_def.xml EX-101.DEF 27200
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE cycc-20220511_lab.xml EX-101.LAB 36811
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cycc-20220511_pre.xml EX-101.PRE 25822
10 EXTRACTED XBRL INSTANCE DOCUMENT tm2215190d1_8k_htm.xml XML 5197
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50626 | Film No.: 22913845
SIC: 2834 Pharmaceutical Preparations